Substance Use, Health, and Functioning Characteristics of Medical Marijuana Program Participants Compared to the General Adult Population in Ontario (Canada)

References

• Aggarwal, S. K., G. T. Carter, M. D. Sullivan, C. Zumbrunnen, R. Morrill, and J. D. Mayer. 2013. Prospectively surveying health-related quality of life and symptom relief in a lot-based sample of medical cannabis-using patients in urban Washington State reveals managed chronic illness and debility. American Journal of Hospice and Palliative Medicine 30 (6):523–31. doi:10.1177/1049909112454215.
   PubMed Web of Science ®Google Scholar
• Agrawal, A., A. J. Budney, and M. T. Lynskey. 2012. The co-occurring use and misuse of cannabis and tobacco: A review. Addiction 107 (7):1221–33. doi:10.1111/add.2012.107.issue-7.
   PubMed Web of Science ®Google Scholar
• Andrews, G., A. Kemp, M. Sunderland, M. Von Korff, T. B. Ustun, and J. S. Ross. 2009. Normative data for the 12 item WHO disability assessment schedule 2.0. Plos One 4 (12):e8343. doi:10.1371/journal.pone.0008343.
   PubMed Web of Science ®Google Scholar
• Aoun, S., D. Pennebaker, and C. Wood. 2004. Assessing population need for mental health care: A review of approaches and predictors. Mental Health Services Research 6 (1):33–46. doi:10.1023/B:MHSR.0000011255.10887.59.
   PubMedGoogle Scholar
• Bachhuber, M. A., B. Saloner, C. O. Cunningham, and C. L. Barry. 2014. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Internal Medicine 174 (10):1668–73. doi:10.1001/jamainternmed.2014.4005.
   PubMed Web of Science ®Google Scholar
• Belle-Isle, L., Z. Walsh, R. Callaway, P. Lucas, R. Capler, R. Kay, and S. Holtzman. 2014. Barriers to access for Canadians who use cannabis for therapeutic purposes. International Journal of Drug Policy 25 (4):691–99. doi:10.1016/j.drugpo.2014.02.009.
   PubMed Web of Science ®Google Scholar
• Boyd, C. J., P. T. Veliz, and S. E. McCabe. 2015. Adolescents’ use of medical marijuana: A secondary analysis of monitoring the future data. Journal of Adolescent Health 57 (2):241–44. doi:10.1016/j.jadohealth.2015.04.008.
   PubMed Web of Science ®Google Scholar
• Compton, W. M., Y. F. Thomas, F. S. Stinson, and B. F. Grant. 2007. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 64 (5):566–76. doi:10.1001/archpsyc.64.5.566.
   PubMed Web of Science ®Google Scholar
• Del Boca, F., and J. Darkes. 2003. The validity of self-reports of alcohol consumption: State of the science and challenges for research. Addiction 98:1–12. doi:10.1046/j.1359-6357.2003.00586.x.
   PubMed Web of Science ®Google Scholar
• Fischer, B., S. Kuganesan, and R. Room. 2015a. Medical marijuana programs: Implications for cannabis control policy: Observations from Canada. International Journal of Drug Policy 26 (1):15–19. doi:10.1016/j.drugpo.2014.09.007.
   PubMed Web of Science ®Google Scholar
• Fischer, B., Y. Murphy, P. Kurdyak, E. Goldner, and J. Rehm. 2015b. Medical marijuana programs—Why might they matter for public health and why should we better understand their impacts? Preventive Medicine Reports 2:53–56. doi:10.1016/j.pmedr.2014.12.006.
   PubMedGoogle Scholar
• Grella, C. E., and L. Rodriguez. 2014. Differences between younger and older medical marijuana users from a cluster-based sample of dispensaries in Los Angeles. Drug and Alcohol Dependence 140:e75–e76. doi:10.1016/j.drugalcdep.2014.02.225.
   Google Scholar
• Grella, C. E., L. Rodriguez, and T. Kim. 2014. Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in Los Angeles. Journal of Psychoactive Drugs 46 (4):263–72. doi:10.1080/02791072.2014.944960.
   PubMed Web of Science ®Google Scholar
• Hall, W., and L. Degenhardt. 2009. Adverse health effects of non-medical cannabis use. The Lancet 374 (9698):1383–91. doi:10.1016/S0140-6736(09)61037-0.
   PubMed Web of Science ®Google Scholar
• Harris, D., R. T. Jones, R. Shank, R. Nath, E. Fernandez, K. Goldstein, and J. Mendelson. 2000. Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members. Journal of Addictive Diseases 19 (3):89–103. doi:10.1300/J069v19n03_07.
   PubMed Web of Science ®Google Scholar
• Harrison, L. 1995. The validity of self-reported data on drug use. Journal of Drug Issues 25 (1):91–111. doi:10.1177/002204269502500107.
   Web of Science ®Google Scholar
• Hasin, D. S., M. Wall, K. M. Keyes, M. Cerdá, J. Schulenberg, P. M. O'Malley, S. Galea, R. Pacula, and T. Feng. 2015. Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: Results from annual, repeated cross-sectional surveys. The Lancet Psychiatry 2 (7):601–608. doi:10.1016/S2215-0366(15)00217-5.
   PubMed Web of Science ®Google Scholar
• Health Canada. 2013. Marihuana Medical Access Program Statistics – Medical Use of Marihuana. Retrieved from http://www.hc-sc.gc.ca/dhp-mps/marihuana/stat/index-eng.php.
   Google Scholar
• Health Canada. 2014. Canadian Alcohol and Drug Use Monitoring Survey (CADUMS): Summary results for 2012. Retrieved from http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/summary-sommaire-eng.php.
   Google Scholar
• Hill, K. P. 2015. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA 313 (24):2474–83. doi:10.1001/jama.2015.6199.
   PubMed Web of Science ®Google Scholar
• Hoffmann, D. E., and E. Weber. 2010. Medical marijuana and the law. New England Journal of Medicine, 362 (16):1453–1457. doi: 10.1056/NEJMp1000695.
   PubMed Web of Science ®Google Scholar
• Ialomiteanu, A. R., and E. M. Adlaf. 2015. CAMH Monitor 2014 Metadata User’s eGuide. Toronto, ON: Centre for Addiction and Mental Health (CAMH).
   Google Scholar
• Ilgen, M. A., K. Bohnert, F. Kleinberg, M. Jannausch, A. S. B. Bohnert, M. Walton, and F. C. Blow. 2013. Characteristics of adults seeking medical marijuana certification. Drug and Alcohol Dependence 132 (3):654. doi:10.1016/j.drugalcdep.2013.04.019.
   PubMed Web of Science ®Google Scholar
• Janichek, J. L., and A. Reiman. 2012. Clinical service desires of medical cannabis patients. Harm Reduction Journal 9 (1):12. doi:10.1186/1477-7517-9-12.
   PubMed Web of Science ®Google Scholar
• Kalant, H., and A. Porath-Waller. 2016. Clearing the smoke on cannabis and cannabinoids: An update. Ottawa, ON: Canadian Centre on Substance Abuse.
   Google Scholar
• Kandel, D., ed. 2002. Stages and pathways of drug involvement: Examining the gateway hypothesis. New York, NY: Cambridge University Press.
   Google Scholar
• Kessler, R. C., G. Andrews, L. J. Colpe, E. Hiripi, D. K. Mroczek, S. L. Normand, E. E. Walters, and A. M. Zaslavsky. 2002. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine 32 (6):959–76. doi:10.1017/S0033291702006074.
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., P. R. Barker, L. J. Colpe, J. F. Epstein, J. C. Gfroerer, E. Hiripi, M. J. Howes, S.-L. T. Normand, R. W. Manderscheid, E. E. Walters, and A. M. Zaslavsky. 2003. Screening for serious mental illness in the general population. Archives of General Psychiatry 60 (2):184–89. doi:10.1001/archpsyc.60.2.184.
   PubMed Web of Science ®Google Scholar
• Lake, S., T. Kerr, and J. Montaner. 2015. Prescribing medical cannabis in Canada: Are we being too cautious? Canadian Journal of Public Health 106 (5):e328–30.
   PubMed Web of Science ®Google Scholar
• Lucas, P., A. Reiman, M. Earleywine, S. K. McGowan, M. Oleson, M. P. Coward, and B. Thomas. 2013. Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Research & Theory 21 (5):435–42. doi:10.3109/16066359.2012.733465.
   Web of Science ®Google Scholar
• Martín-Sánchez, E., T. A. Furukawa, J. Taylor, and J. L. R. Martin. 2009. Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Medicine 10 (8):1353–68. doi:10.1111/j.1526-4637.2009.00703.x.
   PubMed Web of Science ®Google Scholar
• Mehra, R., B. A. Moore, K. Crothers, J. Tetrault, and D. A. Fiellin. 2006. The association between marijuana smoking and lung cancer: A systematic review. Archives of Internal Medicine 166 (13):1359–67. doi:10.1001/archinte.166.13.1359.
   PubMedGoogle Scholar
• Moriarty, D., M. Zack, and R. Kobau. 2003. The Centers for Disease Control and Prevention’s Healthy Days Measure: Population tracking of perceived physical and mental health over time. Health and Quality of Life Outcomes 1:37. doi:10.1186/1477-7525-1-37.
   PubMedGoogle Scholar
• O’Connell, T. J., and C. B. Bou-Matar. 2007. Long term marijuana users seeking medical cannabis in California (2001–2007): Demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction Journal 4 (1):16–16. doi:10.1186/1477-7517-4-16.
   PubMedGoogle Scholar
• Ounpuu, S., P. Krueger, M. Vermeulen, and L. Chambers. 2000. Using the U.S. Behavior Risk Factor Surveillance System’s health related quality of life survey tool in a Canadian city. Canadian Journal of Public Health 91 (1):67–72.
   PubMed Web of Science ®Google Scholar
• Perneger, T. V. 1998. What’s wrong with Bonferroni adjustments. BMJ (Clinical Research Ed.) 316 (7139):1236–38. doi:10.1136/bmj.316.7139.1236.
   PubMed Web of Science ®Google Scholar
• Reiman, A. 2007. Medical cannabis patients: Patient profiles and health care utilization patterns. Complementary Health Practice Review 12 (1):31–50.
   Google Scholar
• Reiman, A. 2009. Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal 6:35. doi:10.1186/1477-7517-6-35.
   PubMed Web of Science ®Google Scholar
• Reinarman, C., H. Nunberg, F. Lanthier, and T. Heddleston. 2011. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. Journal of Psychoactive Drugs 43 (2):128–35. doi:10.1080/02791072.2011.587700.
   PubMed Web of Science ®Google Scholar
• Roy-Byrne, P., C. Maynard, K. Bumgardner, A. Krupski, C. Dunn, I. I. West, D. Donovan, D. C. Atkins, and R. Ries. 2015. Are medical marijuana users different from recreational users? The view from primary care. The American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions 24 (7):599–606. doi:10.1111/ajad.12270.
   PubMed Web of Science ®Google Scholar
• Saunders, J., O. Aasland, T. Babor, J. De La Fuente, and M. Grant. 1993. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 88 (6):791–804. doi:10.1111/add.1993.88.issue-6.
   PubMed Web of Science ®Google Scholar
• Sterne, J. A., and G. Davey Smith. 2001. Sifting the evidence: What’s wrong with significance tests? BMJ (Clinical Research Ed.) 322 (7280):226–31. doi:10.1136/bmj.322.7280.226.
   PubMed Web of Science ®Google Scholar
• Subbaraman, M. S. 2014. Can cannabis be considered a substitute medication for alcohol? Alcohol and Alcoholism 49 (3):292–98. doi:10.1093/alcalc/agt182.
   PubMed Web of Science ®Google Scholar
• Tetrault, J. M., K. Crothers, B. A. Moore, R. Mehra, J. Concato, and D. A. Fiellin. 2007. Effects of marijuana smoking on pulmonary function and respiratory complications. Archives of Internal Medicine 167 (3):221–28. doi:10.1001/archinte.167.3.221.
   PubMedGoogle Scholar
• The Globe and Mail. 2013. By the numbers: Canada’s medical marijuana use. The Globe and Mail. http://www.theglobeandmail.com/news/national/by-the-numbers-canadas-medical-marijuana-use/article14694389/.
   Google Scholar
• Üstün, T. B., S. Chatterji, N. Kostanjsek, J. Rehm, C. Kennedy, J. Epping-Jordan, S. Saxena, M. Von Korff, and C. Pull, and WHO/NIH Joint Project. 2010a. Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization (WHO) 88 (11):815–23. doi:10.2471/BLT.09.067231.
   PubMed Web of Science ®Google Scholar
• Üstün, T. B., S. Chatterji, and J. Rehm. 1998. Limitations of diagnostic paradigm: It doesn’t explain “Need.” Archives of General Psychiatry 55 (12):1145–46. doi:10.1001/archpsyc.55.12.1145-a.
   PubMed Web of Science ®Google Scholar
• Üstün, T. B., N. Kostanjsek, S. Chatterji, and J. Rehm. 2010b. Measuring health and disability: Manual for WHO Disability Assessment Schedule WHODAS 2.0. Geneva, Switzerland: World Health Organization (WHO).
   Google Scholar
• Volkow, N. D., R. D. Baler, W. M. Compton, and S. R. B. Weiss. 2014. Adverse health effects of marijuana use. New England Journal of Medicine 370 (23):2219–27. doi:10.1056/NEJMra1402309.
   PubMed Web of Science ®Google Scholar
• Walsh, Z., R. Callaway, L. Belle-Isle, R. Capler, R. Kay, P. Lucas, and S. Holtzman. 2013. Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. International Journal of Drug Policy 24 (6):511–16. doi:10.1016/j.drugpo.2013.08.010.
   PubMed Web of Science ®Google Scholar
• Woodruff, S. I., and A. M. Shillington. 2016. Sociodemographic and drug use severity differences between medical marijuana users and non-medical users visiting the emergency department. The American Journal on Addictions /American Academy of Psychiatrists in Alcoholism and Addictions 25 (5):385–91. doi:10.1111/ajad.v25.5.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). 2016. The health and social effects of nonmedical cannabis use. Geneva, Switzerland: World Health Organization.
   Google Scholar
• Zhang, Z. F., H. Morgenstern, M. R. Spitz, D. P. Tashkin, G. P. Yu, J. R. Marshall, T. C. Hsu, and S. P. Schantz. 1999. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiology, Biomarkers & Prevention 8 (12):1071–78.
   PubMed Web of Science ®Google Scholar